Effect of recombinant canine interferon-γ on granulocyte-macrophage colony-stimulating factor, transforming growth factor-β and CC chemokine ligand 17 mRNA transcription in a canine keratinocyte cell line (CPEK)

Veterinary Dermatology

Volumn 22, Issue 1, 2011, Pages 24-30

  Shibata, Sanae ^a   Maeda, Sadatoshi ^a   Kondo, Naho ^a   Inoue, Akiko ^a   Maeda, Shingo ^a   Chimura, Naoki ^a   Fukata, Tsuneo ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA; RECOMBINANT PROTEIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; CELL LINE; DOG; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; KERATINOCYTE; METABOLISM;

ANIMALS; CELL LINE; CHEMOKINE CCL17; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON-GAMMA; KERATINOCYTES; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

CANIS FAMILIARIS;

EID: 78651455988     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2010.00897.x     Document Type: Article

References (41)

1. Hillier A, Griffin CE. The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Veterinary Immunology and Immunopathology 2001; 81: 147-51.
2. Halliwell R. Revised nomenclature for veterinary allergy. Veterinary Immunology and Immunopathology 2006; 114: 207-8.
3. Mamessier E, Magnan A. Cytokines in atopic diseases: revisiting the Th2 dogma. European Journal of Dermatology 2006; 16: 103-13.
4. Leung DY. Molecular basis of allergic diseases. Molecular Genetics and Metabolism 1998; 63: 157-67.
5. Barata LT, Ying S, Meng Q et al. IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. Journal of Allergy and Clinical Immunology 1998; 101: 222-30.
6. Nuttall TJ, Knight PA, McAleese SM et al. Expression of Th1, Th2 and immunosuppressive cytokine gene transcripts in canine atopic dermatitis. Clinical and Experimental Allergy 2002; 32: 789-95.
7. Gajewski TF, Goldwasser E, Fitch FW. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor. Journal of Immunology 1988; 141: 2635-42.
8. Jujo K, Renz H, Abe J et al. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. Journal of Allergy and Clinical Immunology 1992; 90: 323-31.
9. Renz H, Jujo K, Bradley KL et al. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. Journal of Investigative Dermatology 1992; 99: 403-8.
10. Iwasaki T, Hasegawa A. A randomized comparative clinical trial of recombinant canine interferon-gamma (KT-100) in atopic dogs using antihistamine as control. Veterinary Dermatology 2006; 17: 195-200.
11. Iwasaki T, Park SJ, Kagawa N et al. Effect of treatment with recombinant canine IFN-γ on the clinical signs, histopathology and Th1/Th2-cytokine mRNA profiles in Shih Tzu dogs and a Basset hound with atopic dermatitis. In: Hillier A, Foster AP, Kwochka KW eds. Advances in Veterinary Dermatology. Oxford: Blackwell Publishing, 2005: 82-88.
12. Werfel T, Morita A, Grewe M et al. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. Journal of Investigative Dermatology 1996; 107: 871-6.
13. Maeda S, Fujiwara S, Omori K et al. Lesional expression of thymus and activation-regulated chemokine in canine atopic dermatitis. Veterinary Immunology and Immunopathology 2002; 88: 79-87.
14. Girolomoni G, Pastore S. The role of keratinocytes in the pathogenesis of atopic dermatitis. Journal of the American Academy of Dermatology 2001; 45: S25-8.
15. Vestergaard C, Bang K, Gesser B et al. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. Journal of Investigative Dermatology 2000; 115: 640-6.
16. Maeda S, Tsukui T, Saze K et al. Production of a monoclonal antibody to canine thymus and activation-regulated chemokine (TARC) and detection of TARC in lesional skin from dogs with atopic dermatitis. Veterinary Immunology and Immunopathology 2005; 103: 83-92.
17. Pastore S, Fanales-Belasio E, Albanesi C et al. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. Journal of Clinical Investigation 1997; 99: 3009-17.
18. Yeo A, Lamb JR. Manipulating the immune response in allergic disease: targeting CD4+ T cells. Trends in Biotechnology 1995; 13: 186-90.
19. Mason D, Powrie F. Control of immune pathology by regulatory T cells. Current Opinion in Immunology 1998; 10: 649-55.
20. Fujii-Maeda S, Kajiwara K, Ikizawa K et al. Reciprocal regulation of thymus and activation-regulated chemokine/macrophage-derived chemokine production by interleukin (IL)-4/IL-13 and interferon-gamma in HaCaT keratinocytes is mediated by alternations in E-cadherin distribution. Journal of Investigative Dermatology 2004; 122: 20-8.
21. Pastore S, Corinti S, La Placa M et al. Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. Journal of Allergy and Clinical Immunology 1998; 101: 538-44.
22. Sumiyoshi K, Nakao A, Setoguchi Y et al. TGF-beta/Smad signaling inhibits IFN-gamma and TNF-alpha-induced TARC (CCL17) production in HaCaT cells. Journal of Dermatological Science 2003; 31: 53-8.
23. Vestergaard C, Kirstejn N, Gesser B et al. IL-10 augments the IFN-gamma and TNF-alpha induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis. Journal of Dermatological Science 2001; 26: 46-54.
24. Uchi H, Terao H, Koga T et al. Cytokines and chemokines in the epidermis. Journal of Dermatological Science 2000; 24(Suppl. 1): S29-38.
25. Shibata S, Maeda S, Tsuchida H et al. Phenotypic analysis for a cell line of canine epidermal keratinocytes. Journal of Veterinary Medical Science 2008; 70: 853-5.
26. Wood SH, Clements DN, McEwan NA et al. Reference genes for canine skin when using quantitative real-time PCR. Veterinary Immunology and Immunopathology 2008; 126: 392-5.
27. Maeda S, Maeda S, Shibata S et al. House dust mite major allergen Der f 1 enhances proinflammatory cytokine and chemokine gene expression in a cell line of canine epidermal keratinocytes. Veterinary Immunology and Immunopathology 2009; 131: 298-302.
28. Mori R, Wang Q, Danenberg KD et al. Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer. Prostate 2008; 68: 1555-60.
29. Fujiwara S, Yasunaga S, Iwabuchi S et al. Cytokine profiles of peripheral blood mononuclear cells from dogs experimentally sensitized to Japanese cedar pollen. Veterinary Immunology and Immunopathology 2003; 93: 9-20.
30. Maeda S, Tsuchida H, Marsella R. Allergen challenge decreases mRNA expression of regulatory cytokines in whole blood of high-IgE beagles. Veterinary Dermatology 2007; 18: 422-6.
31. Heufler C, Koch F, Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. Journal of Experimental Medicine 1988; 167: 700-5.
32. Hancock GE, Kaplan G, Cohn ZA. Keratinocyte growth regulation by the products of immune cells. Journal of Experimental Medicine 1988; 168: 1395-402.
33. Tada Y, Asahina A, Nakamura K et al. Granulocyte/macrophage colony-stimulating factor inhibits IL-12 production of mouse Langerhans cells. Journal of Immunology 2000; 164: 5113-9.
34. Bartz H, Avalos NM, Baetz A et al. Involvement of suppressors of cytokine signaling in toll-like receptor-mediated block of dendritic cell differentiation. Blood 2006; 108: 4102-8.
35. Song MM, Shuai K. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. Journal of Biological Chemistry 1998; 273: 35056-62.
36. Starr R, Willson TA, Viney EM et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387: 917-21.
37. Wolf G, Thaiss F, Stahl RA. Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects. Transplantation 1995; 60: 237-41.
38. Zhang JG, Walmsley MW, Moy JV et al. Differential effects of cyclosporin A and tacrolimus on the production of TGF-beta: implications for the development of obliterative bronchiolitis after lung transplantation. Transplant International 1998; 11(Suppl. 1): S325-7.
39. Shibata S, Maeda S, Chimura N et al. Augmentation of CCL17 and CCL28 gene expression by TNF-alpha, IL-1beta, or IFN-gamma in cultured canine keratinocytes. Research in Veterinary Science 2009 (Epub ahead of print).
40. Nakayama T, Hieshima K, Nagakubo D et al. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. Journal of Virology 2004; 78: 1665-74.
41. Thommesen L, Sjursen W, Gasvik K et al. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. Journal of Immunology 1998; 161: 3421-30.